Irwin Naturals Inc. (CSE:IWIN) said it will release Irwin Naturals Cannabis’ new CBD 25mg Softgels in Canada, available nationwide through the Starseed Medicinal Medical Group platform.
The CBD 25mg Softgel is the first of five CBD and THC products that Irwin Naturals Cannabis plans to launch nationwide in Canada over the next few months through its licensing agreement with Entourage Health Corp. (TSX-V:ENTG)
"We're thrilled to be launching our first cannabis product in Canada," said Klee Irwin, founder of Irwin Naturals Cannabis in a statement. "With our CBD 25mg Softgels, we are bringing a high-quality cannabis-derived CBD oil product to allow consumers to incorporate premium CBD into their daily health regimens. We're excited to be able to bring the benefits of CBD to consumers across the country."
READ: Irwin Naturals closes acquisition of Ketamine Media owner
The full line of Irwin Naturals Cannabis products will be offered as softgels that utilize hemp seed oil and medium-chain triglyceride (MCT) oil. Five different formulations are planned: THC (10 mg THC), CBD (25 mg CBD), 1:1 (10 mg CBD, 10 mg THC), 3:1 (30 mg CBD, 10 mg THC) and a 2:1 formulation that combines THC and the cannabinoid CBN (10 mg THC, 5 mg CBN).
Irwin Naturals was founded in 1994 and is now a brand that is recognized in 80% of American households. Operating profitably for the past 27 years, the firm is seeking to use the equity and power of that brand in emerging markets such as cannabis and psychedelic mental-health clinics.
Contact the author at jon.hopkins@proactiveinvestors.com